Luliderm Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exhibits potent antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation ensures effective penetration into the stratum corneum, providing sustained antifungal action. Luliderm Cream is typically applied once daily to the affected area and surrounding skin for a duration prescribed by the healthcare professional, usually ranging from one to two weeks depending on the infection type and severity. It is well-tolerated with minimal systemic absorption, reducing the risk of systemic side effects. Common adverse reactions may include mild local irritation, burning sensation, or erythema at the application site, which are generally transient. Luliderm Cream should be used with caution in patients with known hypersensitivity to luliconazole or any of the cream’s excipients. It is not recommended for use on mucous membranes or in the eyes. Proper hygiene and adherence to the prescribed treatment regimen are essential to ensure optimal therapeutic outcomes and prevent recurrence.